Long Non-Coding RNA GAS5 Promotes BAX Expression by Competing with microRNA-128-3p in Response to 5-Fluorouracil

Heejin Lee1,2, Hoin Kang1, Chongtae Kim1

  • 1Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Biomedicines
|January 21, 2023
PubMed

Insights

Long non-coding RNA GAS5 is downregulated in chemo-resistant colon cancer. Overexpressing GAS5 enhances anti-cancer drug efficacy by promoting apoptosis via BAX regulation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Drug resistance is a significant challenge in cancer therapy.
  • Mechanisms underlying cancer drug resistance require further elucidation.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in various cellular processes, including cancer progression and drug response.

Purpose of the Study:

  • To investigate the role of lncRNA GAS5 in the development of chemoresistance in colon cancer.
  • To elucidate the molecular mechanism by which GAS5 influences sensitivity to 5-fluorouracil (5-FU).

Main Methods:

  • Analysis of GAS5 expression in 5-FU-resistant colon cancer cell lines.
  • Assessment of cell viability and apoptosis markers (BAX) following GAS5 manipulation.
  • MS2-trap assay combined with RT-qPCR to determine GAS5-mRNA interactions.
  • Investigation of the regulatory relationship between GAS5, BAX, and microRNA-128-3p.

Main Results:

  • GAS5 was significantly downregulated in 5-FU-resistant colon cancer cells.
  • GAS5 downregulation reduced cell viability and BAX protein levels.
  • GAS5 overexpression promoted 5-FU-induced cell death.
  • GAS5 directly binds to the 3'-UTR of BAX mRNA, enhancing its expression by inhibiting miR-128-3p.
  • Ectopic GAS5 expression resensitized resistant cells to anti-cancer drugs.

Conclusions:

  • GAS5 plays a crucial role in overcoming 5-FU resistance in colon cancer.
  • GAS5 promotes apoptosis and enhances chemo-sensitivity by modulating the miR-128-3p/BAX axis.
  • GAS5 represents a potential therapeutic target for improving the efficacy of chemotherapy in resistant cancers.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
76
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
6.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.6K